We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cardinal Health, Inc. (CAH) Soars to 52-Week High, Time to Cash Out?
Read MoreHide Full Article
Have you been paying attention to shares of Cardinal Health (CAH - Free Report) ? Shares have been on the move with the stock up 29.4% over the past month. The stock hit a new 52-week high of $210.33 in the previous session. Cardinal has gained 77.1% since the start of the year compared to the 6.3% move for the Zacks Medical sector and the 13.8% return for the Zacks Medical - Dental Supplies industry.
What's Driving the Outperformance?
The stock has an impressive record of positive earnings surprises, having beaten the Zacks Consensus Estimate in each of the last four quarters. In its last earnings report on October 30, 2025, Cardinal reported EPS of $2.55 versus consensus estimate of $2.21 while it beat the consensus revenue estimate by 8.39%.
For the current fiscal year, Cardinal is expected to post earnings of $9.86 per share on $258.58 in revenues. This represents a 19.66% change in EPS on a 16.18% change in revenues. For the next fiscal year, the company is expected to earn $10.9 per share on $277.02 in revenues. This represents a year-over-year change of 10.53% and 7.13%, respectively.
Valuation Metrics
Though Cardinal has recently hit a 52-week high, what is next for Cardinal? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level.
On this front, we can look at the Zacks Style Scores, as they provide investors with an additional way to sort through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. The idea behind the style scores is to help investors pick the most appropriate Zacks Rank stocks based on their individual investment style.
Cardinal has a Value Score of A. The stock's Growth and Momentum Scores are A and C, respectively, giving the company a VGM Score of A.
In terms of its value breakdown, the stock currently trades at 21.3X current fiscal year EPS estimates, which is a premium to the peer industry average of 15X. On a trailing cash flow basis, the stock currently trades at 18X versus its peer group's average of 12X. Additionally, the stock has a PEG ratio of 1.52. This is good enough to put the company in the top echelon of all stocks we cover from a value perspective, making Cardinal an interesting choice for value investors.
Zacks Rank
We also need to consider the stock's Zacks Rank, as this supersedes any trend on the style score front. Fortunately, Cardinal currently has a Zacks Rank of #2 (Buy) thanks to rising earnings estimates.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Cardinal meets the list of requirements. Thus, it seems as though Cardinal shares could still be poised for more gains ahead.
How Does CAH Stack Up to the Competition?
Shares of CAH have been soaring, and the company still appears to be a decent choice, but what about the rest of the industry? One industry peer that looks good is McKesson Corporation (MCK - Free Report) . MCK has a Zacks Rank of #2 (Buy) and a Value Score of A, a Growth Score of A, and a Momentum Score of D.
Earnings were strong last quarter. McKesson Corporation beat our consensus estimate by 10.54%, and for the current fiscal year, MCK is expected to post earnings of $38.42 per share on revenue of $408.3 billion.
Shares of McKesson Corporation have gained 8% over the past month, and currently trade at a forward P/E of 22.54X and a P/CF of 22.29X.
The Medical - Dental Supplies industry is in the top 22% of all the industries we have in our universe, so it looks like there are some nice tailwinds for CAH and MCK, even beyond their own solid fundamental situation.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cardinal Health, Inc. (CAH) Soars to 52-Week High, Time to Cash Out?
Have you been paying attention to shares of Cardinal Health (CAH - Free Report) ? Shares have been on the move with the stock up 29.4% over the past month. The stock hit a new 52-week high of $210.33 in the previous session. Cardinal has gained 77.1% since the start of the year compared to the 6.3% move for the Zacks Medical sector and the 13.8% return for the Zacks Medical - Dental Supplies industry.
What's Driving the Outperformance?
The stock has an impressive record of positive earnings surprises, having beaten the Zacks Consensus Estimate in each of the last four quarters. In its last earnings report on October 30, 2025, Cardinal reported EPS of $2.55 versus consensus estimate of $2.21 while it beat the consensus revenue estimate by 8.39%.
For the current fiscal year, Cardinal is expected to post earnings of $9.86 per share on $258.58 in revenues. This represents a 19.66% change in EPS on a 16.18% change in revenues. For the next fiscal year, the company is expected to earn $10.9 per share on $277.02 in revenues. This represents a year-over-year change of 10.53% and 7.13%, respectively.
Valuation Metrics
Though Cardinal has recently hit a 52-week high, what is next for Cardinal? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level.
On this front, we can look at the Zacks Style Scores, as they provide investors with an additional way to sort through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. The idea behind the style scores is to help investors pick the most appropriate Zacks Rank stocks based on their individual investment style.
Cardinal has a Value Score of A. The stock's Growth and Momentum Scores are A and C, respectively, giving the company a VGM Score of A.
In terms of its value breakdown, the stock currently trades at 21.3X current fiscal year EPS estimates, which is a premium to the peer industry average of 15X. On a trailing cash flow basis, the stock currently trades at 18X versus its peer group's average of 12X. Additionally, the stock has a PEG ratio of 1.52. This is good enough to put the company in the top echelon of all stocks we cover from a value perspective, making Cardinal an interesting choice for value investors.
Zacks Rank
We also need to consider the stock's Zacks Rank, as this supersedes any trend on the style score front. Fortunately, Cardinal currently has a Zacks Rank of #2 (Buy) thanks to rising earnings estimates.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Cardinal meets the list of requirements. Thus, it seems as though Cardinal shares could still be poised for more gains ahead.
How Does CAH Stack Up to the Competition?
Shares of CAH have been soaring, and the company still appears to be a decent choice, but what about the rest of the industry? One industry peer that looks good is McKesson Corporation (MCK - Free Report) . MCK has a Zacks Rank of #2 (Buy) and a Value Score of A, a Growth Score of A, and a Momentum Score of D.
Earnings were strong last quarter. McKesson Corporation beat our consensus estimate by 10.54%, and for the current fiscal year, MCK is expected to post earnings of $38.42 per share on revenue of $408.3 billion.
Shares of McKesson Corporation have gained 8% over the past month, and currently trade at a forward P/E of 22.54X and a P/CF of 22.29X.
The Medical - Dental Supplies industry is in the top 22% of all the industries we have in our universe, so it looks like there are some nice tailwinds for CAH and MCK, even beyond their own solid fundamental situation.